These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17691376)

  • 1. Management of spasticity in multiple sclerosis by intrathecal baclofen.
    Dario A; Tomei G
    Acta Neurochir Suppl; 2007; 97(Pt 1):189-92. PubMed ID: 17691376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
    Stetkarova I; Brabec K; Vasko P; Mencl L
    Pain Physician; 2015; 18(4):E633-41. PubMed ID: 26218954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
    Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
    Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intrathecal baclofen therapy and management of severe spasticity].
    Naito Y
    Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.
    Farrell R; Summers M; Doogan C; Mulhert N; Keenan E; Buchanan K; Lee H; Padilla H; Stevenson VL
    Mult Scler Relat Disord; 2021 May; 50():102831. PubMed ID: 33618123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal baclofen in the treatment of spasticity, dystonia and vegetative disorders.
    Richard I; Menei P
    Acta Neurochir Suppl; 2007; 97(Pt 1):213-8. PubMed ID: 17691379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.
    Rietman JS; Geertzen JH
    Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity.
    Dan B; Motta F; Vles JS; Vloeberghs M; Becher JG; Eunson P; Gautheron V; Lütjen S; Mall V; Pascual-Pascual SI; Pauwels P; Røste GK
    Eur J Paediatr Neurol; 2010 Jan; 14(1):19-28. PubMed ID: 19541514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
    Sammaraiee Y; Stevenson VL; Keenan E; Buchanan K; Lee H; Padilla H; Farrell RA
    Mult Scler Relat Disord; 2020 Nov; 46():102503. PubMed ID: 33032053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.
    Sadiq SA; Wang GC
    J Neurol; 2006 May; 253(5):563-9. PubMed ID: 16328111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting.
    Gburek-Augustat J; Krause M; Bernhard M; Sorge I; Gräfe D; Siekmeyer M; Nestler U; Merkenschlager A
    Childs Nerv Syst; 2021 Aug; 37(8):2597-2604. PubMed ID: 33834279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe spacticity in multiple sclerosis by continuous intrathecal baclofen].
    Perić P; Antić B; Dincić E; Obradović D; Arsić S
    Vojnosanit Pregl; 2006 Feb; 63(2):187-91. PubMed ID: 16502996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.